Test Information:
Everolimus is a derivative of sirolimus often formulated for oral administration and is synthesized by the introduction of a 2-hydroxyethyl group at the carbon atom at position 40 of sirolimus. The drug has many clinical applications, the most prominent being in organ transplantation, oncology, and cardiology. It has been shown that early replacement of calcineurin inhibitors such as cyclosporin with an everolimus based regimen might improve long-term outcomes in kidney transplant patients.
Specimen Container:
Lavender Top Tube (EDTA)
Specimen Type:
Whole Blood
Required Volume:
4 mL
Patient Preparation:
No Patient Preparation
Notes:
N/A (Not Applicable)
Storage & Stability
(Before Processing)
- Storage: 2 to 8°C
Stability: 7 days
- Storage: 15 to 25°C
Stability: 7 days - Storage: – 20°C
Stability: 7 days
Transport Temperature:
Ref (2°C – 8°C)
Test Category:
Batch
Test Schedule:
Every Thursday Cut-Off 1200H
All specimen received beyond cut-off will be included for the next batch processing.
Results Availability:
Friday, 1200H